Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.5M Sell
308,143
-50,357
-14% -$6.41M 8.87% 2
2026
Q1
$39.7M Buy
358,500
+111,410
+45% +$15.2M 6.94% 3
2025
Q4
$45M Buy
247,090
+64,500
+35% +$11.5M 9.89% 2
2025
Q3
$32M Sell
182,590
-20,200
-10% -$3.38M 8.39% 4
2025
Q2
$29.5M Sell
202,790
-6,400
-3% -$908K 7.28% 5
2025
Q1
$36.6M Hold
209,190
9.51% 3
2024
Q4
$43.9M Buy
209,190
+78,400
+60% +$18.3M 10.75% 4
2024
Q3
$37.6M Sell
130,790
-18,800
-13% -$5.93M 7.12% 4
2024
Q2
$46.9M Hold
149,590
8.22% 3
2024
Q1
$50.3M Sell
149,590
-15,510
-9% -$4.57M 9.34% 2
2023
Q4
$46.7M Sell
165,100
-21,100
-11% -$5.46M 9.5% 1
2023
Q3
$45.9M Hold
186,200
10.1% 1
2023
Q2
$46.6M Buy
186,200
+30,300
+19% +$6.43M 8.71% 2
2023
Q1
$33.3M Buy
155,900
+32,800
+27% +$7.3M 6.48% 6
2022
Q4
$23.9M Buy
+123,100
New +$24.4M 5.52% 11

Other funds holding ICLR

Eagle Health Investments's ICLR Position: Q2 2026 in Review

Eagle Health Investments reduced its Icon (ICLR) stake by 14% in Q2 2026, selling an estimated $6.41M and leaving 308,143 shares worth $53.5M. The position accounts for 8.87% of the portfolio, ranked #2.

Eagle Health Investments first reported a position in ICLR in Q4 2022 and has held it in 15 quarters since. 196 funds tracked by Wall St. Rank hold ICLR as of Q2 2026.

  • Eagle Health Investments held 308,143 shares of Icon worth $53.5M as of Q2 2026.
  • Eagle Health Investments sold 50,357 Icon shares in Q2 2026, an estimated $6.41M.
  • Icon made up 8.87% of Eagle Health Investments's portfolio in Q2 2026, its #2 holding.
  • Eagle Health Investments first reported a position in Icon in Q4 2022 and has held it in 15 quarters since.
  • 196 funds tracked by Wall St. Rank held Icon as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.